Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piccart

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Current management of ovarian carcinosarcomaM S Mano, D D Rosa, E Azambuja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2013
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013A Goldhirsch, E P Winer, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodesF Cardoso, A Di Leo, D Larsimont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)A Awada, I N Bondarenko, J Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
The Hamburg statement: the partnership driving the European agenda on breast cancerJ Jassem, M Buchanan, F Jänicke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancerJ A Kramer, D Curran, M Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2017
Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del PaggioN I Cherny, U Dafni, J Bogaerts, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Clinical phase I trial of marcellomycin with a single-dose scheduleC Nicaise, M Rozencweig, M de Marneffe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancerR Paridaens, C Focan, J Michel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015A S Coates, E P Winer, A Goldhirsch, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Current management of ovarian carcinosarcomaM S Mano, D D Rosa, E Azambuja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2013
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013A Goldhirsch, E P Winer, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodesF Cardoso, A Di Leo, D Larsimont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)A Awada, I N Bondarenko, J Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
The Hamburg statement: the partnership driving the European agenda on breast cancerJ Jassem, M Buchanan, F Jänicke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2000
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancerJ A Kramer, D Curran, M Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2017
Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del PaggioN I Cherny, U Dafni, J Bogaerts, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Clinical phase I trial of marcellomycin with a single-dose scheduleC Nicaise, M Rozencweig, M de Marneffe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancerR Paridaens, C Focan, J Michel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015A S Coates, E P Winer, A Goldhirsch, et al.
Pageof 19